偏头痛药物市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00024005
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

偏头痛药物市场预计在 2023 年至 2031 年期间的复合年增长率为 8.4%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按类型(堕胎医学和预防医学)细分。报告按给药途径(口服、注射和其他)细分。报告按分销渠道(医院药房、零售药房和在线药房)细分。全球分析进一步细分为区域和主要国家。报告提供上述分析和细分的美元价值。

报告目的

The Insight Partners 撰写的《偏头痛药物市场》报告旨在描述当前的形势和未来的增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

偏头痛药物市场细分

 

类型

  • 堕胎医学
  • 预防医学

给药途径

  • 口服
  • 注射
  • 其他的

分销渠道

  • 医院药房
  • 零售药店
  • 网上药店

地理

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

地理

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

偏头痛药物市场:战略洞察

Migraine Headache Drugs Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

偏头痛药物市场增长动力

  • 偏头痛患病率:由于全球患病率较高,偏头痛药物行业正在走下坡路。相对而言,据估计,这种疾病影响全球约 12% 的人群,发病率较高,尤其是 18 至 44 岁的女性。偏头痛患者数量不断增加,因此推动了治疗需求并刺激了偏头痛药物市场。慢性偏头痛的发展速度对残疾造成巨大负担,进一步加剧了对有效药物的需求。
  • 药物新技术的发展:赞扬药物研究的不断进步,开发出有效治疗偏头痛的药物。最新的药物类别,如 CGRP 抑制剂,彻底改变了偏头痛的治疗过程。例如 Aimovig、Emgality 和 Ajovy,它们具有相同的原理来阻断 CGRP,CGRP 是偏头痛病理生理学中的重要分子。新发现的治疗方法已获得 FDA 等监管机构的批准,令市场兴奋不已。
  • 提高认识和诊断:人们越来越关注医疗保健意识,这导致偏头痛的识别和诊断不断增加。越来越多的人寻求医疗帮助并接受偏头痛检测,因此治疗需求随之增加。这些改进的诊断技术和关于偏头痛诱因和症状的更具信息性的提高认识活动使人们更好地获得护理。认识既实现了对迄今为止未被发现的患者进行早期诊断,也可能导致更好的结果和增加药物市场。

偏头痛药物市场未来趋势

  • 预防性治疗转变的部分原因:随着越来越多的医疗保健专业人士认识到早期干预的好处,偏头痛药物市场现在趋向于预防。预防性药物的目的是减少偏头痛发生的频率、严重程度和持续时间。肉毒杆菌毒素注射、抗 CGRP 抗体和 β 受体阻滞剂作为长期替代疗法,越来越受欢迎。这种向预防性治疗的转变正在扩大处方模式患者可用的范围。
  • 采用个性化医疗:它们还影响偏头痛疗法的创新和营销。由于对偏头痛疾病的遗传和生化基础的了解不断增加,制药公司正在努力寻找个性化偏头痛疗法的方法。
  • 数字健康技术的使用:例如,涉及偏头痛治疗方案各个方面的数字健康方法包括使用应用程序、可穿戴设备和远程医疗平台,让患者根据症状跟踪和管理病情。一些在线设备为患者提供了非常高的机会来监测他们的触发因素和药物使用情况,并与医疗保健提供者进行远程咨询。启发式和戴维斯认为,当患者以可访问的方式参与该计划时,这种技术可能不会被忽略,因为它可以补充他们自己未来偏头痛发作的管理。

偏头痛药物市场机会

  • 正在开发的创新新药渠道:偏头痛药物市场将受益于健康的新型创新疗法渠道。药物制造商仍在不断投入研发资金,以开发下一代偏头痛疗法。这些治疗方法通常针对偏头痛病理生理学中涉及的机制进行特定抑制,例如神经炎症过程。这种创新渠道有望扩大患者的治疗选择,并为市场创造增长机会。
  • 非处方偏头痛药物的兴起:非处方偏头痛治疗领域的机会越来越多。人们对偏头痛的认识有所提高,许多患者选择自行用药,而不是去专业诊所。有效的非处方偏头痛药物(如组合止痛药和消炎药)已经有一个成熟的利基市场。公司可以进一步扩展其在这一非处方领域的产品组合,让更广泛的人群(包括那些无法立即联系到医疗保健专业人员的人)能够缓解偏头痛。
  • 合作与战略伙伴关系:制药公司、生物技术公司和供应商之间的战略合作或伙伴关系安排将为偏头痛药物的增长提供最佳广告。整合的资源将使这些大公司能够提供研究、开发和营销工作,推出针对现有偏头痛病理的新疗法。这种关系可能导致药物的共同开发,其中一方或双方能够营销单个产品或组合疗法。

 

偏头痛药物市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响偏头痛药物市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的偏头痛药物市场细分和地理位置。

Migraine Headache Drugs Market
  • 获取偏头痛药物市场的区域特定数据

偏头痛药物市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)8.4%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 堕胎医学
  • 预防医学
按给药途径
  • 口服
  • 注射
  • 其他的
按分销渠道
  • 医院药房
  • 零售药店
  • 网上药店
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 雅培实验室
  • 艾尔建公司(Allergan Plc)
  • 阿斯利康
  • 卫材株式会社
  • Endo 国际有限公司
  • 葛兰素史克公司
  • Impax实验室
  • 强生公司
  • 默克公司

 

偏头痛药物市场参与者密度:了解其对业务动态的影响

偏头痛药物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在偏头痛药物市场运营的主要公司有:

  1. 雅培实验室
  2. 艾尔建公司(Allergan Plc)
  3. 阿斯利康
  4. 卫材株式会社
  5. Endo 国际有限公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Migraine Headache Drugs Market

 

  • 了解偏头痛药物市场的主要参与者概况

 

 

主要卖点

 

  • 全面覆盖:该报告全面涵盖了偏头痛药物市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,偏头痛药物市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment accounts for highest revenue by type in 2023?

Abortive Medicine segment, by type, dominated the market in 2023.

Which region dominated the Migraine Headache Drugs market in 2023?

North America region dominated the Migraine Headache Drugs market in 2023.

What are the factor that act as a opportunity for market growth?

Pipeline for Innovative New Drugs in Development act as a opportunity for growth of the market in forecast period.

What is the expected CAGR of the Migraine Headache Drugs Market?

The Migraine Headache Drugs Market is estimated to witness a CAGR of 8.4% from 2023 to 2031

What are the driving factors impacting the Migraine Headache Drugs market?

The major factors driving the Migraine Headache Drugs market are:

1. Migraine disorder prevalence

2. Development of New Technologies in Medication

Which are some of the players operating in the Migraine Headache Drugs market?

Players operating in the market are Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc, Impax Laboratories, Johnson and Johnson, Merck and Co., Pfizer Inc.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Abbott Laboratories
2. Allergan Plc.
3. AstraZeneca
4. Eisai Co., Ltd.
5. Endo International Plc.
6. GlaxoSmithKline Plc
7. Impax Laboratories
8. Johnson and Johnson
9. Merck and Co.
10. Pfizer Inc.
11. Amgen
12. Teva Pharma
13. Eli Lilly

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.